Literature DB >> 19941679

Effects of magnesium on postprandial serum lipid responses in healthy human subjects.

Yoshimi Kishimoto1, Mariko Tani, Harumi Uto-Kondo, Emi Saita, Maki Iizuka, Hirohito Sone, Kuninobu Yokota, Kazuo Kondo.   

Abstract

Postprandial hyperlipidaemia has been recognised to be a risk factor for atherosclerosis development. Epidemiological and animal studies have shown that Mg intake is inversely associated with some risk factors of atherosclerosis, including lipid metabolism. The present study was performed to determine the effects of Mg supplementation on postprandial responses in serum lipid levels. We used bittern (Nigari, in Japanese), a natural MgCl(2) solution from sea or salt lake water, for Mg supplementation. In a two-way, randomised, crossover study, sixteen healthy male volunteers consumed 30 g butter with or without 5 ml bittern containing 500 mg of Mg. Fasting and postprandial blood samples were taken 2, 3, 4 and 6 h after ingestion. Postprandial lipid responses were evaluated by serum TAG, chylomicron TAG, apo-B48, remnant-like particle cholesterol (RLP-C) and NEFA concentrations. We found that the serum and the chylomicron TAG responses after the fat load were reduced and delayed by Mg supplementation. The concentrations of apo-B48 (P < 0.05), RLP-C (P < 0.05) and NEFA (P < 0.05) were significantly lower at 2 h after the fat-with-Mg meal compared with the fat-only meal. The present study indicated that Mg supplementation could inhibit fat absorption and improve postprandial hyperlipidaemia in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941679     DOI: 10.1017/S0007114509992716

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  12 in total

Review 1.  Nutritional Supplementation for the Prevention and/or Treatment of Gestational Diabetes Mellitus.

Authors:  Jasmine F Plows; Clare M Reynolds; Mark H Vickers; Philip N Baker; Joanna L Stanley
Journal:  Curr Diab Rep       Date:  2019-08-01       Impact factor: 4.810

2.  Drinking deep seawater decreases serum total and low-density lipoprotein-cholesterol in hypercholesterolemic subjects.

Authors:  Zhao-Yang Fu; Feili Lo Yang; Hsin-Wen Hsu; Yi-Fa Lu
Journal:  J Med Food       Date:  2012-03-16       Impact factor: 2.786

3.  Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis.

Authors:  D T Dibaba; P Xun; A D Fly; K Yokota; K He
Journal:  Diabet Med       Date:  2014-11       Impact factor: 4.359

4.  Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes.

Authors:  Dae Jung Kim; Pengcheng Xun; Kiang Liu; Catherine Loria; Kuninobu Yokota; David R Jacobs; Ka He
Journal:  Diabetes Care       Date:  2010-08-31       Impact factor: 19.112

5.  Magnesium intake is inversely associated with the risk of metabolic syndrome in the REasons for geographic and racial differences in stroke (REGARDS) cohort study.

Authors:  Daniel T Dibaba; Cheng Chen; Liping Lu; Aurelian Bidulescu; Alyce D Fly; Pengcheng Xun; Suzanne E Judd; Mary Cushman; Ka Kahe
Journal:  Clin Nutr       Date:  2020-10-21       Impact factor: 7.324

6.  Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Mohammad Alizadeh; Majid Karandish; Mohammad Asghari Jafarabadi; Lida Heidari; Roshan Nikbakht; Hossein Babaahmadi Rezaei; Reihaneh Mousavi
Journal:  Nutr Metab (Lond)       Date:  2021-06-06       Impact factor: 4.169

Review 7.  Hass avocado composition and potential health effects.

Authors:  Mark L Dreher; Adrienne J Davenport
Journal:  Crit Rev Food Sci Nutr       Date:  2013       Impact factor: 11.176

8.  Nigari (deep seawater concentrate) enhances the treadmill exercise performance of gerbils.

Authors:  M-L Wang; Y-J Chen; F-C Cheng
Journal:  Biol Sport       Date:  2014-01-22       Impact factor: 2.806

9.  Deep sea water modulates blood pressure and exhibits hypolipidemic effects via the AMPK-ACC pathway: an in vivo study.

Authors:  Ming-Jyh Sheu; Pei-Yu Chou; Wen-Hsin Lin; Chun-Hsu Pan; Yi-Chung Chien; Yun-Lung Chung; Fon-Chang Liu; Chieh-Hsi Wu
Journal:  Mar Drugs       Date:  2013-06-17       Impact factor: 5.118

10.  Refeeding and metabolic syndromes: two sides of the same coin.

Authors:  O A Obeid; D H Hachem; J J Ayoub
Journal:  Nutr Diabetes       Date:  2014-06-30       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.